Taking into account the important role of OS in the development of DKD, with the NRF2/KEAP1/ARE pathway as a major modulator of the oxidative state of the cell, focusing on this pathophysiological branch can prove to be the key to a better management of this problematic disease. Here, KEAP1 is linked to diabetic kidney disease.